Tumor Volume Estimation on BraTS GD-enhancing 2023 (test shift)
87.25Coverage (%)W-Oracle
Evaluation results
| Method | Links | ||||
|---|---|---|---|---|---|
| W-OracleTarget coverage=90%, Setting=Calib ID vs. Test Shift2024.07 | 87.25 | 0.7 | 9 | 0.85 | |
| W-LatentTarget coverage=90%, Setting=Calib ID vs. Test Shift2024.07 | 86.19 | 0.81 | 8.6 | — | |
| Standard Conformal PredictionTarget coverage=90%, Setting=Calib ID vs. Test Shift2024.07 | 81.29 | — | 7 | — |